Welcome : Guest

Sage Therapeutics, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Sage Therapeutics, Inc., which is principally a Clinical-Stage Biopharmaceutical Company. Illustrated with 27 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-65318
Price: $1350
Company Type: Public
Pages: 29
Date: January 2017
Market Data Tables: 27

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Anti-Psychotics......3
Table 1: Anti-Psychotics Market Worldwide (2015-2020) in US$ '000......3
Table 2: Prescribed Atypical Antipsychotic Market by Type in the US (2015) - Percentage Share Breakdown by Value for 5HT1A Agonist, H1, Antagonist, D2 and 5HT2, D2 and 5HT2A, and Partial D2 Agonist......4
Central Nervous System (CNS) Drugs......5
Table 3: Central Nervous System (CNS) Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Depression, Epilepsy, Narcotic Analgesics, Non-Narcotic Analgesics, Psychotic Disorders and Others......5
Table 4: Central Nervous System Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Anti-Migraine, Antipsychotics, Newer Antidepressants, Older Antidepressants, SNRI's, SSRI’s, Tranquilizers, and Others......6
Depression Drugs......7
Table 5: Depression Drugs Market by Product Segment in the US (2015) - Percentage Share Breakdown by Value for Bupropion Hydrochloride XL, Cymbalta, Escitalopram Oxalate, Lexapro, Pristiq, and Others......7
Epilepsy Drugs......8
Table 6: Epilepsy Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Carbamazepine Generics, Depakote/ER Franchise (ABT), Depakote/ER Generics, Dilant in (PFE), Gabapent in Generics, Keppra Generics, Keppra/XR (UCB), Lamictal/XR (GSK), Lyrica (PFE), Trileptal (NVS), Vimpat (UCB), and Others......8
Pediatric Growth Hormone Deficiency (GHD)......9
Table 7: Pediatric Growth Hormone Deficiency (GHD) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, Japan and United States......9
Table 8: Pediatric Growth Hormone Deficiency (GHD) Market by Product in the US (2015) - Percentage Share Breakdown by Value Genotropin, Humatrope, Norditropin and FlexPro (NordiFlex), Nutropin AQ and Others......10
Growth Hormone......11
Table 9: Growth Hormone Market by Growth Disorder Indication in Europe (2015) - Percentage Share Breakdown by Value for Adult Growth Hormone Deficiency (GHD), Pediatric Growth Hormone Deficiency (GHD), Turner Syndrome and Others......11
Table 10: Growth Hormone Market by Growth Disorder Indication in Japan (2015) - Percentage Share Breakdown by Value for Pediatric Growth Hormone Deficiency (GHD) and Turner Syndrome......12
Table 11: Growth Hormone Market by Growth Disorder Indication in the US (2015) - Percentage Share Breakdown by Value for Adult Growth Hormone Deficiency (GHD), Idiopathic Short Stature (ISS), Pediatric Growth Hormone Deficiency (GHD), Turner Syndrome and Others......13
Psychiatric Hospitals......14
Table 12: Psychiatric Hospital Revenues by Segment in the US (2015) - Percentage Share Breakdown by Value for Acute Care, Education Services, Occupational Therapy, Recreational Therapy, and Others......14
Oxcarbazepine Drugs......15
Table 13: Oxcarbazepine Drug Usage by Indication in the US (2015) - Percentage Market Share Breakdown by Volume for Epilepsy, Psychiatric Disorders and Others......15
Table 14: Oxcarbazepine Drug Usage by Prescriber in the US (2015) - Percentage Market Share Breakdown by Volume for Internal Medicine & Pediatrics, Neurology, Nurse, Psychiatry, and Others......16
Topiramate Drugs......17
Table 15: Topiramate Drug Usage by Indication in the US (2015) - Percentage Market Share Breakdown by Volume for Epilepsy, Migraine Headache, Psychiatric Disorders, Weight Loss, and Others......17
Table 16: Topiramate Drug Usage by Prescriber in the US (2015) - Percentage Market Share Breakdown by Volume for Family Practice, Internal Medicine & Pediatrics, Neurology, Nurse, Osteopathic Medicine, Psychiatry, and Others......18
Acute Behavioural Treatment......19
Table 17: Market Shares of Leading Acute Behavioural Treatment Service Providers Worldwide (2015) - Percentage Breakdown by No. of Beds for Accreditation Commission for Health Care, Inc. (ACHC), Aurora Behavioral Health Care, Universal Health Services, Inc., and Others......19
Antipsychotics......20
Table 18: Anti-Psychotic Market by Drug Type Worldwide (2015) - Percentage Share Breakdown by Value for Abilify, Abilify Maintena, Invega Sustenna, Latuda, Risperdal Consta, Seroquel XR, and Others......20
Table 19: Market Shares of Leading Prescribed Atypical Antipsychotic Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Bristol-Myers Squibb Company, Janssen Pharmaceuticals, Inc., Sunovion Pharmaceuticals, Inc., and Johnson & Johnson Private Limited......21
Table 20: Market Shares of Leading Prescribed Atypical Antipsychotic Brands in the US (2015) - Percentage Share Breakdown by Value for Abilify, Invega, Latuda, Risperdal, Seroquel, and Others......22
Table 21: New Prescription Market for Atypical Antipsychotic Drugs in the US (2015) - Percentage Share Breakdown by Value Sales for Abilify (Otsuka/ Bristol-Myers Squibb Company), Fanapt (Novartis), Geodon (Pfizer, Inc.), Invega (Johnson & Johnson), Latuda (Sunovion), Olanzapine (Generic Zyprexa), Risperidone (Generic Risperdal), Saphris (Merck & Company, Inc.), Seroquel (AstraZeneca Plc), and Zyprexa (Eli Lilly and Company)......23
Central Nervous System (CNS) Medicines......24
Table 22: Market Shares of Leading Central Nervous System Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc (AZN), Bristol-Myers Squibb Company (BMY), Eli Lilly And Co (LLY), GlaxoSmithKline Plc (GSK), Johnson & Johnson, Merck & Co., Inc. (MRK), Novartis AG (NVS), Pfizer, Inc. (PFE), Shire Plc (SHPGY), and Others......24
Table 23: Market Shares of Leading Central Nervous System (CNS) Medicine Manufacturers by Value Sales in India (2015) - Percentage Breakdown for Torrent Pharmaceuticals Ltd., and Others......25
Epilepsy Therapeutics......26
Table 24: Market Shares of Leading Epilepsy Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for GlaxoSmithKline Plc, Johnson & Johnson, Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......26
Drugs for Post-Traumatic Stress Disorder (PTSD)......27
Table 25: Market Shares of Leading Drugs for Post-Traumatic Stress Disorder (PTSD) Treatment in the US (2015) - Percentage Share Breakdown by Value for Citalopram, Clonazepam, Escitalopram, Quetiapine, Quetiapine, Sertraline, and Others......27
Treating Thoracic Aortic Aneurysms (TAA)......28
Table 26: Market Shares of Leading Medical Device Manufacturers for Treating Thoracic Aortic Aneurysms (TAA) Disorders in Europe (2015) - Percentage Breakdown by Value for Cook Group, Inc., Gore & Associates, Inc., Medtronic, Inc., and Others......28
Table 27: Market Shares of Leading Medical Device Manufacturers for Treating Thoracic Aortic Aneurysms (TAA) Disorders in the US (2015) - Percentage Breakdown by Value for Cook Group, Inc., Medtronic, Inc., W. L. Gore & Associates, Inc., and Others......29